Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.07 USD | +0.67% | -3.46% | +16.28% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.28% | 13.64B | |
+7.76% | 294B | |
+5.32% | 146B | |
+55.38% | 128B | |
+17.95% | 80.27B | |
+8.97% | 74.75B | |
+19.90% | 62.53B | |
+8.29% | 57.13B | |
+9.99% | 48.14B | |
+27.44% | 34.96B |
- Stock Market
- Equities
- OVV Stock
- News Ovintiv Inc.
- Transcript : Ovintiv Inc., Q4 2023 Earnings Call, Feb 28, 2024